Highbridge Capital Management’s IVERIC bio ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-4,925
Closed -$227K – 1672
2016
Q3
$227K Buy
+4,925
New +$278K ﹤0.01% 1135
2015
Q4
– Sell
-159,067
Closed -$6.45M – 1889
2015
Q3
$6.45M Buy
159,067
+42,357
+36% +$2.24M 0.1% 247
2015
Q2
$6.08M Buy
116,710
+52,873
+83% +$2.63M 0.08% 263
2015
Q1
$2.97M Buy
63,837
+53,945
+545% +$2.8M 0.04% 438
2014
Q4
$444K Buy
+9,892
New +$415K 0.01% 858
2014
Q3
– Sell
-88,468
Closed -$3.47M – 1417
2014
Q2
$3.74M Buy
+88,468
New +$3.25M 0.05% 299

Other funds holding ISEE

Highbridge Capital Management's ISEE Position: Q4 2016 in Review

Highbridge Capital Management sold out of IVERIC bio (ISEE) in Q4 2016, closing a stake of 4,925 shares — an estimated $227K sold.

Highbridge Capital Management first reported a position in ISEE in Q2 2014 and held it in 6 quarters. The position peaked at $6.45M in Q3 2015. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

  • Highbridge Capital Management reported no remaining IVERIC bio position as of Q4 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 4,925 IVERIC bio shares in Q4 2016, an estimated $227K.
  • Highbridge Capital Management first reported a position in IVERIC bio in Q2 2014 and held it in 6 quarters.
  • Highbridge Capital Management's IVERIC bio position peaked at $6.45M in Q3 2015.
  • 137 funds tracked by Wall St. Rank held IVERIC bio as of Q4 2016.

Based on Highbridge Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.